Top companies

ASIANPAINT - 2459.9 (0.53%) AXISBANK - 1160.3 (-0.9%) BAJAJFINSV - 2072.1 (-0.59%) BAJFINANCE - 1029 (0.34%) BHARTIARTL - 1929.1 (-0.5%) BPCL - 330.1 (-0.09%) COALINDIA - 393.4 (-0.17%) HDFCBANK - 948.6 (-0.9%) HEROMOTOCO - 5275 (-1.78%) HINDUNILVR - 2556.9 (1.38%) ICICIBANK - 1380.8 (-0.97%) INDUSINDBK - 741.6 (-1.81%) ITC - 401.3 (-0.47%) KOTAKBANK - 2031.8 (-0.78%) MARUTI - 16232 (0.84%) ONGC - 239 (0.99%) RELIANCE - 1385.8 (-0.29%) SBIN - 866.6 (-0.46%) TATAMOTORS - 683.05 (-2.61%) TATASTEEL - 172.94 (-0.2%) TCS - 3041.4 (-0.69%) TITAN - 3422.7 (-0.48%) WIPRO - 244.71 (-1.97%)
TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

Buy Gland Pharma, target price Rs 5000: Emkay Global

14 Dec , 2021   By : monika singh


Buy Gland Pharma, target price Rs 5000: Emkay Global

Emkay Global has buy call on Gland Pharma Ltd. with a target price of Rs 5000. The current market price of Gland Pharma Ltd. is Rs 3624.35.

Time period given by analyst is one year when Gland Pharma Ltd. price can reach defined target.

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 59158.23 Crore) operating in Pharmaceuticals sector.

Gland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Export Incentives for the year ending 31-Mar-2021.

Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 1131.67 Crore, down -6.92 % from last quarter Total Income of Rs 1215.74 Crore and up 32.85 % from last year same quarter Total Income of Rs 851.85 Crore. Company reported net profit after tax of Rs 302.08 Crore in latest quarter.


0 Comment


LEAVE A COMMENT


Growmudra © 2026 all right reserved

Partner With Us